1.Clinical practice guidelines on leptospirosis in children 2019
Maria Anna P. Bañ ; ez, M.D ; Melba V. Marasigan, M.D. ; Ma. Liza Antoinette M. Gonzales, M.D., MSc ; Grace Devota G. Go, M.D. ; Fatima I. Gimenez, M.D. ; Mary Antonette C. Madrid, M.D. ; John Andrew T. Camposano, M.D. ; Jennifer M. Nailes, M.D., MSPH ; Ma. Lucila M. Perez, M.D., MSc
Pediatric Infectious Disease Society of the Philippines Journal 2023;24(1):5-69
Executive Summary
Leptospirosis is a disease prevalent mostly in tropical and subtropical countries. Its potential to be a concerning
problem emerges with the onset of the rainy season, as flooding and heavy rainfall facilitate disease epidemics. Among
those at risk of contracting the disease are field workers, veterinarians, sewer workers, military personnel and those
who swim or wade in contaminated waters.
In the absence of an existing evidence-based guideline for the pediatric age group, this first edition hopes to
standardize approach to diagnosis, antibiotic management, and prevention of leptospirosis. The intended users are
primary care physicians, family medicine physicians, pediatricians, and other healthcare workers involved in the
management of leptospirosis in children.
Ten priority questions were identified by a group of experts composed of an oversight committee, a guideline
writing panel, and a technical review committee. The GRADE methodology was used to determine the quality of
evidence of each recommendation. The draft recommendations (summarized below) were finalized after these were
presented to and voted on by a panel of stakeholders.
2.Consensus statement on Singapore integrated 24-hour activity guide for children and adolescents.
Benny Kai Guo LOO ; Benedict TAN ; Michael Yong Hwa CHIA ; Poh Chong CHAN ; Dinesh SIRISENA ; Mohammad Ashik ZAINUDDIN ; Jean Yin OH ; Oon Hoe TEOH ; Teresa Shu Zhen TAN ; Micheal Chee Meng LIM ; Ethel Jie Kai LIM ; Falk MÜLLER-RIEMENSCHNEIDER ; Ngiap Chuan TAN ; Ratnaporn SIRIAMORNSARP ; Terry Chin Chye TEO ; Phaik Ling QUAH ; Victor Samuel RAJADURAI ; Kok Hian TAN ; Kee Chong NG
Annals of the Academy of Medicine, Singapore 2022;51(5):292-299
INTRODUCTION:
Lifestyle activities, such as regular physical activity, are important for good metabolic health and the prevention of non-communicable diseases. Epidemiological studies highlight an increase in the proportion of overweight children in Singapore. A workgroup was formed to develop recommendations to encourage children and adolescents (aged 7-17 years) to adopt a holistic approach towards integrating beneficial activities within a daily 24-hour period for good metabolic and general health.
METHODS:
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision framework was employed to formulate the public health question, assess the evidence and draw conclusions for the guide. The evidence for international 24-hour movement guidelines, and guidelines for physical activity, sedentary behaviour, and sleep and eating habits were reviewed. An update of the literature review from August 2018 to end of September 2020 was conducted through an electronic search of Medline and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases.
RESULTS:
Ten consensus statements were developed. The statements focused on the overall aim of achieving good metabolic health through integration of these activities and initiatives: light and moderate- to vigorous-intensity physical activity on a regular basis; muscle- and bone-strengthening activities; limiting sedentary behaviour; regular and adequate sleep; good eating habits and choosing nutritionally balanced foods and drinks; practise safety in exercise; and aiming to achieve more or all aforementioned recommendations for the best results.
CONCLUSION
This set of recommendations provides guidance to encourage Singapore children and adolescents to adopt health-beneficial activities within a 24-hour period.
Adolescent
;
Child
;
Exercise
;
Humans
;
Public Health
;
Sedentary Behavior
;
Singapore
;
Sleep
3.Proposed case rates for acute coronary syndrome and budget impact analysis: Executive summary
Bernadette A. Tumanan-Mendoza ; Victor L. Mendoza ; Felix Eduardo R. Punzalan ; Noemi S. Pestañ ; o ; April Ann A. Bermudez-de los Santos ; Eric Oliver D. Sison ; Eugenio B. Reyes ; Karen Amoloza-de Leon ; Nashiba M. Daud ; Maria Grethel C. Dimalala-Lardizaba ; Orlando R. Bugarin ; Rodney M. Jimenez ; Domicias L. Albacite ; Ma. Belen A. Balagapo ; Elfred M. Batalla ; Jonathan James G. Bernardo ; Helen Ong Garcia ; Amibahar J. Karim ; Gloria R. Lahoz ; Neil Wayne C. Salces
Philippine Journal of Cardiology 2022;50(2):10-15
BACKGROUND
Coronary artery disease is the leading cause of death in the Philippines and can present as acute coronary syndrome. Hospitalization for ACS has epidemiologic and economic burden. In fact, last 2017, there were 1.52% or 152 admissions for every 10,000 hospitalized patients for medical conditions in PhilHealth-accredited hospitals locally. However, coronary angioplasty was performed in only less than 1% of these cases mainly because of its cost and the out-of-pocket expense that the treatment entail, when primary percutaneous intervention has been proven to be effective in reducing mortality in STEMI and early invasive intervention performed during index hospitalization for NSTEMI is likewise recommended. Moreover, there is a big disparity between the current case rates for ACS for medical therapy alone and for invasive intervention compared to the actual ACS hospitalization cost.
OBJECTIVES1) To propose revisions to the current PhilHealth case rates for acute coronary syndrome (ACS); and 2) To determine the budget impact of the proposed ACS case rates.
METHODSThe Philippine Heart Association with the assistance of a technical working group undertook the study. A panel of experts composed of general and invasive cardiologists from Luzon, Visayas, and Mindanao was formed. The ACS hospitalization costs based on the recent study by Mendoza were presented and discussed during the focus group discussions with the panelists. Issues pertinent to their localities that may affect the costs were discussed. The proposed revised costs on the particular ACS conditions and therapeutic regimens were then voted and agreed upon. A budget impact analysis of the proposed case rates was then performed.
RESULTSThe proposed case rates for ACS ranged from Php 80,000 (for low risk unstable angina given medical treatment) to Php 530,000 (for ST-elevation myocardial infarction initially given a thrombolytic agent then underwent PCI which necessitated the use of three stents). The budget impact analysis showed that the proposed ACS rates would require an additional PHP 1.5 billion to 2.3 billion during the first year of a 3- versus 5-year implementation period, respectively. The period of implementation will be affected by budgetary constraints as well as the availability of cardiac catheterization facilities in the country.
CONCLUSIONThe proposed revised PhilHealth hospitalization coverage for ACS is more reflective or realistic of the ACS hospitalization costs in contrast with the current PhilHealth case rates. The corresponding budget impact analysis of these proposed case rates showed that PHP 7.6 billion is needed for full implementation. However, given the budget constraints, the percentage of the total costs for the first and subsequent years of implementation may be modified.
4.Revised PhilHealth case rates for hospitalization for acute coronary syndrome in the Philippines
Felix Eduardo R. Punzalan ; Noemi S. Pestañ ; o ; April Ann A. Bermudez-delos Santos ; Bernadette A. Tumanan-Mendoza ; Victor L. Mendoza ; Eric Oliver D. Sison ; Karen Amoloza-De Leon ; Eugenio B. Reyes ; Nashiba M. Daud ; Maria Grethel C. Dimalala-Lardizabal ; Orlando R. Bugarin ; Rodney M. Jimenez ; Domicias L. Albacite ; Ma. Belen A. Balagapo ; Elfred M. Batalla ; Jonathan James G. Bernardo ; Helen Ong Garcia ; Amibahar J. Karim ; Gloria R. Lahoz ; Neil Wayne C. Salces
Philippine Journal of Cardiology 2022;50(2):16-25
BACKGROUND
Hospitalization for acute coronary syndrome (ACS) has epidemiologic and economic burden. The coverage for hospitalization in the local setting is much less than the actual costs. Many patients do not consent to or avail of the optimal and timely management because of financial challenges.
OBJECTIVESThe paper aimed to propose revised PhilHealth case rates/packages for ACS, namely: 1) unstable angina (UA), 2) non-ST-elevation myocardial infarction (NSTEMI), and 3) STelevation myocardial infarction (STEMI).
METHODSA consensus panel was organized to provide inputs such as cost and other matters pertaining to the revision of the PhilHealth ACS case rates/packages. The results of the cost of hospitalization of the different ACS conditions derived from a study on hospitalization cost for ACS were presented to the panel. Several focused group discussions were held afterward for propositioning new case rates through votation and by nominal group technique, using the costs from the study as the bases of rate adjustment.
RESULTSFinal costs agreed upon by the consensus panel for medical management alone for UA, NSTEMI, and STEMI were adjusted or amended in increments of Php 20,000, (80,000, 100,000, and 120,000, respectively). Thrombolysis of a patient admitted for STEMI increased the cost to Php 140,000. An additional cost of Php 150,000 was added on top of the cost for medical management and coronary angiogram for NSTE- ACS for PCI with use of a single stent. For STEMI, the same category had an additional cost of Php 180,000. For each additional stent used for all clinical scenarios undergoing PCI, Php 65,000 was added, to cover up to a total of 3 stents.
CONCLUSIONBased on the consensus process with Philippine Heart Association ACS panelists, the cost proposed ranges from 80,000 pesos to 530,000 pesos depending on the clinical scenarios.
Acute Coronary Syndrome
5.Budget impact analysis of the proposed PhilHealth case rates for acute coronary syndrome in the Philippines
Bernadette A. Tumanan-Mendoza ; Victor L. Mendoza ; Felix Eduardo R. Punzalan ; Noemi S. Pestañ ; o ; April Ann A. Bermudez-delos Santos ; Eric Oliver D. Sison ; Eugenio B. Reyes ; Karen Amoloza-de Leon ; Nashiba M. Daud ; Maria Grethel C. Dimalala-Lardizaba ; Orlando R. Bugarin ; Rodney M. Jimenez ; Domicias L. Albacite ; Ma. Belen A. Balagapo ; Elfred M. Batalla ; Jonathan James G. Bernardo ; Helen Ong Garcia ; Amibahar J. Karim ; Gloria R. Lahoz ; Neil Wayne C. Salces
Philippine Journal of Cardiology 2022;50(2):26-33
OBJECTIVE
This study aimed to determine the budget impact of the proposed revised PhilHealth case rate packages for acute coronary syndrome (ACS).
METHODSThis budget impact analysis used the static approach or cost calculator modeling method. The prevalence of hospitalization for coronary artery disease in all PhilHealth-accredited hospitals in the country in 2017 and the data from the ACS registry project of the Philippine Heart Association were used in this study. The study multiplied the present PhilHealth coverage with the number of ACS hospitalization claims to come up with the total cost of ACS hospitalization in the next three years with the assumptions that the eligible population and the ACS PhilHealth case rates will remain constant for these years. The future ACS hospitalization costs were also determined if the proposed case rates were used rather than the current PhilHealth case rates. The cost of re-admissions was considered as savings in hospitalization cost (due to prevention of admissions if the appropriate interventions were given) and were deducted from the future total cost of ACS hospitalizations.
RESULTSThe annual total ACS hospitalization cost using the current case rates was Php 1,134,683,000. Using the proposed case rates, the total hospitalization costs over five years was Php 2,653,019,000 in the first year (proposed case rates implemented to only 20% of the ACS patients) and increased to Php 8,726,364,000 by year 5 (full implementation of the proposed case rates or to 100% of ACS patients). This resulted in a lower incremental cost in the first year of implementation compared with a less gradual implementation over 3 years. The total incremental costs would amount to PHP7.6 billion for full implementation.
CONCLUSIONThe study provided the budget impact of the proposed revised ACS case rates. The incremental cost is relatively huge, however the benefits of providing coverage of guidelinedirected therapy including invasive strategies for ACS must be considered.
6.Causes, functional outcomes and healthcare utilisation of people with cerebral palsy in Singapore.
Zhi Min NG ; Jeremy B LIN ; Poh Choo KHOO ; Victor Samuel RAJADURAI ; Derrick W S CHAN ; Hian Tat ONG ; Janice WONG ; Chew Thye CHOONG ; Kim Whee LIM ; Kevin B L LIM ; Tong Hong YEO
Annals of the Academy of Medicine, Singapore 2021;50(2):111-118
INTRODUCTION:
A voluntary cerebral palsy (CP) registry was established in 2017 to describe the clinical characteristics and functional outcomes of CP in Singapore.
METHODS:
People with CP born after 1994 were recruited through KK Women's and Children's Hospital, National University Hospital and Cerebral Palsy Alliance Singapore. Patient-reported basic demographics, service utilisation and quality of life measures were collected with standardised questionnaires. Clinical information was obtained through hospital medical records.
RESULTS:
Between 1 September 2017 and 31 March 2020, 151 participants were recruited. A majority (n=135, 89%) acquired CP in the pre/perinatal period, where prematurity (n=102, 76%) and the need for emergency caesarean section (n=68, 50%) were leading risk factors. Sixteen (11%) of the total participants had post-neonatally acquired CP. For predominant CP motor types, 109 (72%) had a spastic motor type; 32% with spastic mono/hemiplegia, 41% diplegia, 6% triplegia and 21% quadriplegia. The remaining (42, 27.8%) had dyskinetic CP. Sixty-eight (45.0%) participants suffered significant functional impairment (Gross Motor Functional Classification System levels IV-V). Most participants (n=102, 67.5%) required frequent medical follow-up (≥4 times a year).
CONCLUSION
Optimisation of pre- and perinatal care to prevent and manage prematurity could reduce the burden of CP and their overall healthcare utilisation.
7. Detection of dengue virus serotype 3 in Cajamarca, Peru: Molecular diagnosis and clinical characteristics
Miguel AGUILAR-LUIS ; Wilmer SILVA-CASO ; Yordi TARAZONA-CASTRO ; Ronald AQUINO-ORTEGA ; Angela CORNEJO-TAPIA ; Juana VALLE-MENDOZA ; Miguel AGUILAR-LUIS ; Wilmer SILVA-CASO ; Yordi TARAZONA-CASTRO ; Ronald AQUINO-ORTEGA ; Juana VALLE-MENDOZA ; Hugo CARRILLO-NG ; Eduardo VERNE ; Sungmin KYM ; Luis DEL VALLE ; Jorge BAZN-MAYRA ; Victor ZAVALETA-GAVIDIA ; Daniel CORNEJO-PACHERRES
Asian Pacific Journal of Tropical Medicine 2021;14(10):456-462
Objective: To describe and molecularly characterize an outbreak of dengue virus (DENV) infection in Cajamarca, an Andean region in Peru. Methods: A total of 359 serum samples from patients with acute febrile illness were assessed for the presence of DENV via RT-PCR, ELISA NS1, IgM and IgG in Cajamarca, Peru from January 2017 to June 2017. The evaluation of the different diagnostic tests and their applicability was performed. Results: Dengue virus was detected in 24.7% of samples by RTPCR. Meanwhile, serological analysis detected 30.3% positive cases via ELISA NS1 antigen, 16.7% via ELISA IgG and 9.7% via ELISA IgM. Most of the cases corresponded to DENV-3 (77.5%). The use of RT-PCR performed better in primary infections (P<0.01), while detection of ELISA IgM performed better in secondary infections (P<0.01). The combination of NS1 and IgM performed better than the other assays in detecting primary (92.5%) and secondary infections (96.6%). The most frequent symptoms associated with fever were headaches, myalgias, and arthralgias across all groups. Conclusions: We report an important outbreak of dengue infection caused by DENV-3 in Cajamarca, Peru. Our findings encourage the use of NS1 antigen and IgM co-detection. These findings demonstrate an increasing expansion of DENV-3 in Peru and highlight the importance of molecular diagnosis and serotype characterization among the clinically defined dengue cases to strengthen the Peruvian epidemiological surveillance.
8.Reconstruction of post-burn anterior neck contractures using a butterfly design free anterolateral thigh perforator flap
Alexandre G. LELLOUCH ; Zhi Yang NG ; Victor POZZO ; Tabrez SUFFEE ; Laurent A. LANTIERI
Archives of Plastic Surgery 2020;47(2):194-197
Anterior neck burns represent a major reconstructive challenge due to severe sequalae including restriction in movement and poor aesthetic outcomes. Common treatment options include skin grafting with/without dermal matrices, and loco-regional and distant free flap transfers with/without prior tissue expansion. Such variation in technique is largely influenced by the extent of burn injury requiring resurfacing. In order to optimize like-for-like reconstruction of the anterior neck, use of wide, thin and long flaps such as the anterolateral thigh (ALT) perforator flap have been reported with promising results. Of note, some patients have a tendency towards severe scar contractures, which may be contributed by the greater extent of inflammation during wound healing. We report our experience at 4 years’ follow-up after secondary reconstruction of severe, anterior neck burn contractures in two patients by harvesting the ALT flap with a butterfly design. This technique provides adequate wound resurfacing of the burned neck and surrounding areas, and provides good neck extensibility by addressing both anterior and lateral aspects of the scar defect simultaneously. Such a flap design reduces tension on wound edges and thus, the risk of contracture recurrence in what remains a particularly challenging type of burn reconstruction.


Result Analysis
Print
Save
E-mail